Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
نویسندگان
چکیده
منابع مشابه
Home intravenous antibiotics for cystic fibrosis.
BACKGROUND Recurrent endobronchial infection in cystic fibrosis (CF) requires treatment with intravenous antibiotics for several weeks usually in hospital, affecting health costs and quality of life for patients and their families. OBJECTIVES To determine whether home intravenous antibiotic therapy in CF is as effective as inpatient intravenous antibiotic therapy and if it is preferred by ind...
متن کاملHome versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis.
To compare the effectiveness of home versus hospital intravenous (IV) antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis (CF). A retrospective chart review was performed of 143 encounters for pulmonary exacerbations in 50 patients with CF. All encounters were categorized into two groups based on location of completion of antibiotic therapy: hospital group comp...
متن کاملTreatment of pulmonary exacerbations in cystic fibrosis.
Pulmonary exacerbations have very important consequences in cystic fibrosis (CF), both in terms of current morbidity as well as implications for long term morbidity and mortality. Even though there is no universally agreed definition of pulmonary exacerbation, prompt and aggressive treatment with a multidisciplinary approach is recommended. Maintenance treatments reduce the risk of exacerbation...
متن کاملPulmonary exacerbations in cystic fibrosis and bronchiectasis.
unique characteristics. Taking these characteristics into account should enable a more accurate assessment of disease severity. Numerous examples exist of disease-specific scores that outperform generic scores, 14 including the PSI in the context of patients hospitalised with CAP. The study by Barlow et al extends this view to CURB65 in relation to SEWS and SIRS. However, the patient cohort in ...
متن کاملComparison of nebulized and intravenous terbutaline during exacerbations of pulmonary infection in patients with cystic fibrosis.
Twenty three patients completed a double-blind study, comparing intravenous and nebulized terbutaline, during the first four days of a pulmonary exacerbation of cystic fibrosis (CF), with follow-up to day 10. Routine treatment with chest physiotherapy and appropriate intravenous antibiotics was given to all patients. The best peak flow rate (PF), forced expiratory volume in one second (FEV1) an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2015
ISSN: 1465-1858
DOI: 10.1002/14651858.cd009730.pub2